Copyright
©The Author(s) 2017.
World J Gastroenterol. Jul 21, 2017; 23(27): 5018-5033
Published online Jul 21, 2017. doi: 10.3748/wjg.v23.i27.5018
Published online Jul 21, 2017. doi: 10.3748/wjg.v23.i27.5018
Table 3 Bcl-2 expression and clinicopathological features of colorectal cancer
Clinicopathologial features | No. of studies | No. of patients | Pooled OR (95%CI) | P value | Heterogeneity | |
I² | P value | |||||
Gender (male vs female) | 11 | 1671 | 1.125 (0.865-1.463) | 0.381 | 30.2% | 0.158 |
Tumor location (colon vs rectum) | 8 | 1361 | 1.168 (0.922-1.480) | 0.199 | 0% | 0.628 |
tumor grade (1 + 2 vs 3) | 12 | 1454 | 2.475 (1.307-4.685) | 0.005 | 68.4% | 0.000 |
Ducks' stage (A + B vs C + D) | 12 | 1572 | 1.630 (1.009-2.632) | 0.046 | 78.1% | 0.000 |
- Citation: Huang Q, Li S, Cheng P, Deng M, He X, Wang Z, Yang CH, Zhao XY, Huang J. High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis. World J Gastroenterol 2017; 23(27): 5018-5033
- URL: https://www.wjgnet.com/1007-9327/full/v23/i27/5018.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i27.5018